Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors (AflacST1402)
A Phase 1 Study Using Simvastatin in Combination With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
Sponsor: Children's Healthcare of Atlanta
Listed as NCT02390843, this PHASE1 trial focuses on Clear Cell Sarcoma and Ewings Sarcoma and remains completed. Sponsored by Children's Healthcare of Atlanta, it has been updated 9 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
May 2020 — Jan 2021 [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Sep 2019 — May 2020 [monthly]
Recruiting PHASE1
▶ Show 4 earlier versions
-
Jul 2019 — Sep 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Jul 2019 [monthly]
Recruiting PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Healthcare of Atlanta
- Emory University
For direct contact, visit the study record on ClinicalTrials.gov .